Anticancer Drug Impact on DNA – A Study by Neutron Spectroscopy coupled to Synchrotron-based FTIR and EXAFS
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 12 - Engineering
- Output identifier
- 85349717
- Type
- E - Conference contribution
- DOI
-
10.1039/C8CP05881D
- Title of conference / published proceedings
- Physical Chemistry Chemical Physics: high quality research in physical chemistry, chemical physics and biophysical chemistry
- First page
- 4162
- Volume
- 21
- Issue
- 8
- ISSN
- 1463-9076
- Open access status
- Compliant
- Month of publication
- January
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
10
- Research group(s)
-
C - CEAS
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- This work has led to collaboration with Astra Zeneca through the NorthWest Centre for Advanced Drug Delivery NoWCADD and the Department of Pharmacy. In addition, the UoM has invested in new IR and Raman spectroscopy facilities.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
